<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biosci Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Biosci. Rep</journal-id>
<journal-id journal-id-type="hwp">ppbioscirep</journal-id>
<journal-id journal-id-type="publisher-id">BSR</journal-id>
<journal-title-group>
<journal-title>Bioscience Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">0144-8463</issn>
<issn pub-type="epub">1573-4935</issn>
<publisher>
<publisher-name>Portland Press Ltd.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28533427</article-id>
<article-id pub-id-type="pmc">6434077</article-id>
<article-id pub-id-type="doi">10.1042/BSR20160570</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
</subj-group>
<subj-group subj-group-type="overline">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>17</subject>
<subject>47</subject>
<subject>14</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Copy number variations independently induce autism spectrum disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yingjun</surname>
<given-names>Xie</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn1a">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haiming</surname>
<given-names>Yuan</given-names>
</name>
<xref ref-type="aff" rid="A2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="A3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn1a">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mingbang</surname>
<given-names>Wang</given-names>
</name>
<xref ref-type="aff" rid="A4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="A5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="A6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liangying</surname>
<given-names>Zhong</given-names>
</name>
<xref ref-type="aff" rid="A7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiaxiu</surname>
<given-names>Zhou</given-names>
</name>
<xref ref-type="aff" rid="A8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bing</surname>
<given-names>Song</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qibin</surname>
<given-names>Yin</given-names>
</name>
<xref ref-type="aff" rid="A9">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiaofang</surname>
<given-names>Sun</given-names>
</name>
<xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="COR1"></xref>
</contrib>
<aff id="A1"><label>1</label>Key Laboratory for Major Obstetric Diseases of Guangdong Province, Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, Guangdong, PR China</aff>
<aff id="A2"><label>2</label>Guangzhou Kingmed Center for Clinical Laboratory Co., Ltd., Guangzhou 510330, Guangdong, PR China</aff>
<aff id="A3"><label>3</label>KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou 510330, Guangdong, PR China</aff>
<aff id="A4"><label>4</label>Shenzhen Following Precision Medical Research Institute, Shenzhen 518000, Guangdong, China</aff>
<aff id="A5"><label>5</label>ImunoBio Co., Ltd., Shenzhen 518000, Guangdong, China</aff>
<aff id="A6"><label>6</label>Key Laboratory of Birth Defects, Children’s Hospital of Fudan University, Shanghai 201102, China</aff>
<aff id="A7"><label>7</label>Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, Guangdong, PR China</aff>
<aff id="A8"><label>8</label>Division of Psychology, Shenzhen Children’s Hospital, Shenzhen, Guangdong, China</aff>
<aff id="A9"><label>9</label>Northeast Yucai School, Shenyang 110179, Liaoning, PR China</aff>
</contrib-group>
<author-notes>
<corresp id="COR1"><bold>Correspondence:</bold> Sun Xiaofang (<email>xiaofangsun@hotmail.com</email>)</corresp>
<fn fn-type="equal" id="fn1a">
<label>*</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epreprint">
<day>22</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<day>31</day>
<month>8</month>
<year>2017</year>
</pub-date>
<volume>37</volume>
<issue>4</issue>
<elocation-id>BSR20160570</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© 2017 The Author(s).</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License 4.0 (CC BY)</ext-link>.</license-p>
</license>
</permissions>
<self-uri xlink:href="bsr-37-bsr20160570.pdf" xlink:title="pdf"></self-uri>
<abstract>
<p>The examination of copy number variation (CNV) is critical to understand the etiology of the CNV-related autism spectrum disorders (ASD). DNA samples were obtained from 64 ASD probands, which were genotyped on an Affymetrix CytoScan HD platform. qPCR or FISH were used as a validation for some novel recurrent CNVs. We further compared the clinical phenotypes of the genes in the Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources (DECIPHER) database with these overlapping genes. Using vast, readily available databases with previously reported clinically relevant CNVs from human populations, the genes were evaluated using Enrichment Analysis and GO Slim Classification. By using the Ploysearch2 software, we identified the interaction relationship between significant genes and known ASD genes. A total of 29 CNVs, overlapping with 520 genes, including 315 OMIM genes, were identified. Additionally, myocyte enhancer factor 2 family (MEF2C) with two cases of CNV overlapping were also identified. Enrichment analysis showed that the 520 genes are most likely to be related to membrane components with protein-binding functions involved in metabolic processes. In the interaction network of those genes, the known ASD genes are mostly at the core position and the significant genes found in our samples are closely related to the known ASD genes. CNVs should be an independent factor to induce autism. With the strategy of our study, we could find the ASDs candidate genes by CNV data and review certain pathogenesis of this disorder. Those CNVs were associated with ASD and they may contribute to ASD by affecting the ASD-related genes.</p>
</abstract>
<kwd-group>
<kwd>Autism spectrum disorders</kwd>
<kwd>Copy number variation</kwd>
<kwd>Enrichment Analysis</kwd>
<kwd>Gene</kwd>
<kwd>Syndrome</kwd>
</kwd-group>
<counts>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p>ASDs (OMIM 209850) represent a group of neurodevelopmental disorders present in 1% of the population, characterized by impairments in communication and reciprocal social interactions [<xref ref-type="bibr" rid="B1">1</xref>]. Approximately 10% of the ASD population possesses large chromosomal rearrangements [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. In recent years, chromosomal microarray analyses (CMA) have offered high diagnostic ability for the detection of genomic CNVs in clinical diagnostics. While whole-exome and whole-genome technologies identify interesting single nucleotide variants and show promise in detecting in/dels and copy number changes in ASDs, the genetics of ASDs are heterogeneous and not fully understood [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. CNVs alter the genome structure leading to Mendelian diseases and complex traits, including ASDs. The contribution of CNVs to genomic disorders is not only via <italic>de novo</italic> occurrence, X-linked and recessive inheritance but also through mosaicism, imprinting, digenic inheritance and gene copy number dose dependent effects [<xref ref-type="bibr" rid="B4">4</xref>]. Thus, it is be important to relate the genes affected with CNVs to clinical and functional phenotypic features.</p>
<p>Several CNV studies in autism have identified associated genes and loci in European individuals and Han Chinese population controls [<xref ref-type="bibr" rid="B5">5–8</xref>]. Genetic studies on ASD in Han Chinese individuals have primarily been presented as case reports or association studies of particular common single nucleotide polymorphisms in ASD populations of European ancestry [<xref ref-type="bibr" rid="B9">9</xref>]. However, in the present study, we identified autism-associated genes from CNVs in 64 ASD samples and databases, and conducted additional analyses of these genes overlapping with enrichment analysis to further improve the results obtained from previous studies [<xref ref-type="bibr" rid="B5">5</xref>–<xref ref-type="bibr" rid="B8">8</xref>].</p>
</sec>
<sec id="sec2" sec-type="methods">
<title>Experimental procedures</title>
<sec id="sec2-1">
<title>Sample selection</title>
<p>A total of 64 ASD-affected individuals and their families were referred to the Clinical Genetics Service for genetic testing. The probands diagnosis and study inclusion criteria were completed as previously described [<xref ref-type="bibr" rid="B9">9</xref>]. The Autism Behavior Checklist (ABC) and Childhood Autism Rating Scale (CARS) were used for the diagnosis. We assessed ASD probands with standardized measures of intelligence, language, and adaptive function and collected information on developmental, medical, and physical measures and family history (Supplementary material). All data were collected with the informed consent of the patients. Ethical approval for the present study was obtained from the hospital.</p>
<sec id="sec2-1-1">
<title>Consent for publication</title>
<p>The consent to publish has been obtained from the guardians of all the involved children.</p>
</sec>
<sec id="sec2-1-2">
<title>Ethical approval</title>
<p>Ethical approval for the present study was obtained from the Ethics Committee of the Third Affiliated Hospital of Guangzhou Medical University.</p>
</sec>
</sec>
<sec id="sec2-2">
<title>Genotyping and variant identification</title>
<p>DNA was isolated from 64 samples with ASD using the QIAamp DNA Mini Kit (Qiagen Benelux B.V., Venlo, Netherlands). Genotyping was performed on the Affymetrix CytoScanHD platform (Santa Clara, CA, U.S.A.) according to the manufacturer’s instructions. The ChAS software package (Santa Clara, CA, U.S.A.) was used for all the analyses. The cutoffs for the detection criteria for CNVs were set at 200 kb for gains, 100 kb for losses and 10000 kb for Regions of Homozygosity(ROH).</p>
<p>All observed copy number changes were compared with the CNVs annotated in the Database of Genomic Variants (DGV; <ext-link ext-link-type="uri" xlink:href="http://projects.tcag.ca/variation/">http://projects.tcag.ca/variation/</ext-link>) and the UCSC genome browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>). The gene content of CNVs of interest were determined using the UCSC Browser based on GRCH37. CNVs located in segmental duplications and repetitive regions were removed, and CNVs overlapping with the in-house benign CNV database were also removed. Each of the CNVs were further evaluated with respect to the affected genes likely to be associated with ASD phenotypic features observed in the patients.</p>
</sec>
<sec id="sec2-3">
<title>CNV verification and representation</title>
<p>Two independent methods were used for verifying the accuracy of our CNV algorithm. First, FISH was used when once the novel recurrent CNVs were detected, some of the results had already been published [<xref ref-type="bibr" rid="B10">10</xref>]. Second, 20 CNV regions at different sizes were randomly selected and qPCR technology was used for detection. Each PCR detection system was repeated three times and the corresponding control groups were set. Compared with the control region, in the detection regions, only the copy number greater than 1.4 times or less than 0.7 times, could be considered as copy number gain (gene duplication) or copy number loss (gene deletion). In addition, S.D. of the multiple must be less than 1 to assure the reliability of the experiment.</p>
</sec>
<sec id="sec2-4">
<title>Database mining</title>
<p>In addition, the intersecting CNV regions were extracted as relatively reliable CNVs associated with autism. The CNVs were further analyzed for the functional annotation of genes, transcripts, and drugs and disease relationships, and the relationship between autism and this information was further analyzed. We focused on the affected genes, including encoding and non-coding genes. The genes identified in the database were defined as having suspected gene associations with autism. We further compared the clinical phenotypes of the genes in the Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources (DECIPHER) database with these overlapping genes.</p>
</sec>
<sec id="sec2-5">
<title>Functional analysis</title>
<p>The bioinformatics analysis for gene functional analysis was performed using WebGestalt (<ext-link ext-link-type="uri" xlink:href="http://bioinfo.vanderbilt.edu/webgestalt/">http://bioinfo.vanderbilt.edu/webgestalt/</ext-link>) [<xref ref-type="bibr" rid="B11">11</xref>]. Moreover, we also analyzed the relation of enriched GO item and the associated genes between them.</p>
</sec>
<sec id="sec2-6">
<title>Comparison with other similar studies</title>
<p>In order to better study the CNVs found in our study, we also made a comparison with the database. We extracted the CNV regions that contain the ASD-related genes from the clinical variation achieved in the dbVar database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/dbvar">https://www.ncbi.nlm.nih.gov/dbvar</ext-link>) of NCBI and downloaded the ASD-related CNV regions reported in the autism databases, SFARI gene database (<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/autdb">https://gene.sfari.org/autdb</ext-link>) and National Database for Autism Research (NDAR) database (<ext-link ext-link-type="uri" xlink:href="https://ndar.nih.gov/">https://ndar.nih.gov/</ext-link>).</p>
<p>In order to further investigate the relation between those genes and ASD, we first collected the genes associated with ASD reported in the literatures by using the Ploysearch2 software (<ext-link ext-link-type="uri" xlink:href="https://ploysearch.cs.ualberta.ca/">https://ploysearch.cs.ualberta.ca/</ext-link>) and then identified the interaction/relationship between significant genes and known genes.</p>
</sec>
<sec id="sec2-7" sec-type="data-availability">
<title>Availability of supporting data</title>
<p>Affymetrix cytoscan HD (<ext-link ext-link-type="uri" xlink:href="http://media.affymetrix.com/support/technical/datasheets/cytoscan_hd_datasheet.pdf">http://media.affymetrix.com/support/technical/datasheets/cytoscan_hd_datasheet.pdf</ext-link>).</p>
<p>Chromosome Analysis Suite Software, Version 3.1 (<ext-link ext-link-type="uri" xlink:href="http://www.affymetrix.com/support/technical/software_downloads.affx">http://www.affymetrix.com/support/technical/software_downloads.affx</ext-link>).</p>
</sec>
</sec>
<sec id="sec3" sec-type="results">
<title>Results</title>
<p>Amongst a cohort of ASD patients, SNP array identified 29 (45%, 29/64) CNVs: 9.3% of probands (6/64) carried a recurrent microdeletion/duplication syndrome (<xref ref-type="table" rid="T1">Table 1</xref>); and 19 non-recurrent CNVs (<xref ref-type="table" rid="T2">Table 2</xref>). Additionally, <italic>MEF2C</italic> with two cases of CNVs overlap were also identified (<xref ref-type="table" rid="T3">Table 3</xref>). These CNVs overlapped with 520 genes, including 315 OMIM genes, present on chromosomes 2, 4, 5, 7, 8, 12, 14, 15, 16, and 22. We compared these 520 genes using WebGestalt (total number of user IDs: 520). A total of 496 user IDs were unambiguously mapped to 487 unique Entrez Gene IDs, and 24 user IDs were mapped to multiple Entrez Gene IDs or could not be mapped to any Entrez Gene ID. Thus, the Enrichment Analysis and GO Slim Classification was based on the 487 unique Entrez Gene IDs. The results of the molecular functional classification, showing each biological process and cellular component category, are presented in <xref ref-type="table" rid="T4">Table 4</xref>.
<table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Recurrent CNVs in ASDs</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Sample ID</th><th align="left" colspan="1" rowspan="1">Size (kbp)</th><th align="left" colspan="1" rowspan="1">Gene count</th><th align="left" colspan="1" rowspan="1">OMIM® genes count</th><th align="left" colspan="1" rowspan="1">Microarray nomenclature</th><th align="left" colspan="1" rowspan="1">Syndrome overlap</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><bold>1471</bold></td><td colspan="1" rowspan="1">11269.38</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">55</td><td colspan="1" rowspan="1">arr[hg19] 3q27.2q29(184,522,306-195,791,682)×1</td><td colspan="1" rowspan="1">3q29 microdeletion syndrome</td></tr><tr><td colspan="1" rowspan="1"><bold>7714</bold></td><td colspan="1" rowspan="1">2248.396</td><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">arr[hg19] 5p15.33(113,576-2,361,972)×1</td><td colspan="1" rowspan="1">Cri du chat syndrome</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">10854.223</td><td colspan="1" rowspan="1">122</td><td colspan="1" rowspan="1">74</td><td colspan="1" rowspan="1">arr[hg19] 16q23.2(79,281,580-90,155,062)×3</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"><bold>7756</bold></td><td colspan="1" rowspan="1">1421.098</td><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">arr[hg19] 7q11.23(72,725,760-74,146,858)×3</td><td colspan="1" rowspan="1">7q11.23 duplication syndrome</td></tr><tr><td colspan="1" rowspan="1"><bold>4876</bold></td><td colspan="1" rowspan="1">232.163</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">arr[hg19] 16p11.2(28,819,028-29,051,191)×1</td><td colspan="1" rowspan="1">16p11.2-p12.2 microdeletion syndrome</td></tr><tr><td colspan="1" rowspan="1"><bold>7687</bold></td><td colspan="1" rowspan="1">577.588</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">arr[hg19] 16p11.2(29,567,295-30,144,883)×1</td><td colspan="1" rowspan="1">16p11.2-p12.2 microdeletion syndrome</td></tr><tr><td colspan="1" rowspan="1"><bold>2543</bold></td><td colspan="1" rowspan="1">9079.75</td><td colspan="1" rowspan="1">131</td><td colspan="1" rowspan="1">76</td><td colspan="1" rowspan="1">arr[hg19] 22q13.2q13.33(42,118,088-51,197,838)×1</td><td colspan="1" rowspan="1">22q13 deletion syndrome</td></tr><tr><td colspan="1" rowspan="1"><bold>4229</bold></td><td colspan="1" rowspan="1">903.193</td><td colspan="1" rowspan="1">35</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">arr[hg19] 22q13.33(50,294,532–51,197,725)×1</td><td colspan="1" rowspan="1">22q13 deletion syndrome</td></tr></tbody></table></table-wrap>
<table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Non-recurrent CNVs in ASDs</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Sample ID</th><th align="left" colspan="1" rowspan="1">Size (kbp)</th><th align="left" colspan="1" rowspan="1">Microarray nomenclature</th><th align="left" colspan="1" rowspan="1">Genes</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><bold>1033</bold></td><td colspan="1" rowspan="1">211.662</td><td colspan="1" rowspan="1">arr[hg19] 2q36.3(230,659,011-230,870,673)×3</td><td colspan="1" rowspan="1">TRIP12<xref ref-type="table-fn" rid="T2TFN1">*</xref>, FBXO36<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>7817</bold></td><td colspan="1" rowspan="1">550.981</td><td colspan="1" rowspan="1">arr[hg19] 2q37.3(240,739,224-241,290,205)×3</td><td colspan="1" rowspan="1">MIR4786, NDUFA10<xref ref-type="table-fn" rid="T2TFN1">*</xref>, OR6B2, PRR21, OR6B3, MYEOV2, OTOS<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>9266</bold></td><td colspan="1" rowspan="1">233.526</td><td colspan="1" rowspan="1">arr[hg19] 3q28(188,332,838-188,566,364)×1</td><td colspan="1" rowspan="1">LPP<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>7824</bold></td><td colspan="1" rowspan="1">369.331</td><td colspan="1" rowspan="1">arr[hg19] 4q24(107,035,056-107,404,387)×1</td><td colspan="1" rowspan="1">TBCK, AIMP1<xref ref-type="table-fn" rid="T2TFN1">*</xref>, GIMD1</td></tr><tr><td colspan="1" rowspan="1"><bold>7857</bold></td><td colspan="1" rowspan="1">376.335</td><td colspan="1" rowspan="1">arr[hg19] 4q35.2(189,007,828-189,384,163)×3</td><td colspan="1" rowspan="1">TRIML2, TRIML1, LOC401164</td></tr><tr><td colspan="1" rowspan="1"><bold>3101</bold></td><td colspan="1" rowspan="1">176.934</td><td colspan="1" rowspan="1">arr[hg19] 5q14.3(88,132,559-88,309,493)×1</td><td colspan="1" rowspan="1">MEF2C<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>7857</bold></td><td colspan="1" rowspan="1">2289.57</td><td colspan="1" rowspan="1">arr[hg19] 5q14.3(88,196,115-90,485,685)×1</td><td colspan="1" rowspan="1">MEF2C<xref ref-type="table-fn" rid="T2TFN1">*</xref>, MIR3660, CETN3<xref ref-type="table-fn" rid="T2TFN1">*</xref>, MBLAC2, POLR3G, LYSMD3, GPR98<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>3322</bold></td><td colspan="1" rowspan="1">896.359</td><td colspan="1" rowspan="1">arr[hg19] 8q23.3(116,237,764-117,134,123)×1</td><td colspan="1" rowspan="1">TRPS1<xref ref-type="table-fn" rid="T2TFN1">*</xref>, LINC00536</td></tr><tr><td colspan="1" rowspan="1"><bold>7032</bold></td><td colspan="1" rowspan="1">386.355</td><td colspan="1" rowspan="1">arr[hg19] 8p22(17,371,318-17,757,673)×1</td><td colspan="1" rowspan="1">SLC7A2<xref ref-type="table-fn" rid="T2TFN1">*</xref>, PDGFRL<xref ref-type="table-fn" rid="T2TFN1">*</xref>, MTUS1<xref ref-type="table-fn" rid="T2TFN1">*</xref>, FGL1<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>8690</bold></td><td colspan="1" rowspan="1">151.812</td><td colspan="1" rowspan="1">arr[hg19] 12q13.11(47,139,554-47,291,366)×1</td><td colspan="1" rowspan="1">SLC38A4<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>4211</bold></td><td colspan="1" rowspan="1">252.233</td><td colspan="1" rowspan="1">arr[hg19] 14q13.1(33,428,360-33,680,593)×1</td><td colspan="1" rowspan="1">NPAS3<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>1248</bold></td><td colspan="1" rowspan="1">440.507</td><td colspan="1" rowspan="1">arr[hg19] 15q13.3(32,003,537-32,444,044)×3</td><td colspan="1" rowspan="1">CHRNA7<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>4626</bold></td><td colspan="1" rowspan="1">126.31</td><td colspan="1" rowspan="1">arr[hg19] 15q15.3(43,907,775-44,034,085)×1</td><td colspan="1" rowspan="1">STRC<xref ref-type="table-fn" rid="T2TFN1">*</xref>, CATSPER2<xref ref-type="table-fn" rid="T2TFN1">*</xref>, CKMT1A<xref ref-type="table-fn" rid="T2TFN1">*</xref>, CATSPER2P1</td></tr><tr><td colspan="1" rowspan="1"><bold>5977</bold></td><td colspan="1" rowspan="1">142.21</td><td colspan="1" rowspan="1">arr[hg19] 15q11.2(22,770,421-22,912,631)×1</td><td colspan="1" rowspan="1">TUBGCP5<xref ref-type="table-fn" rid="T2TFN1">*</xref>, CYFIP1<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>5977</bold></td><td colspan="1" rowspan="1">274.255</td><td colspan="1" rowspan="1">arr[hg19] 15q11.2(22,917,396-23,191,651)×1</td><td colspan="1" rowspan="1">CYFIP1<xref ref-type="table-fn" rid="T2TFN1">*</xref>, NIPA2<xref ref-type="table-fn" rid="T2TFN1">*</xref>, NIPA1<xref ref-type="table-fn" rid="T2TFN1">*</xref>, LOC283683, WHAMMP3</td></tr><tr><td colspan="1" rowspan="1"><bold>7756</bold></td><td colspan="1" rowspan="1">165.56</td><td colspan="1" rowspan="1">arr[hg19] 15q15.3(43,889,174-44,054,734)×1</td><td colspan="1" rowspan="1">RNU6-28P, CKMT1B<xref ref-type="table-fn" rid="T2TFN1">*</xref>, STRC<xref ref-type="table-fn" rid="T2TFN1">*</xref>, CATSPER2<xref ref-type="table-fn" rid="T2TFN1">*</xref>, CKMT1A8, CATSPER2P1, PDIA3<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>9943</bold></td><td colspan="1" rowspan="1">143.975</td><td colspan="1" rowspan="1">arr[hg19] 16p12.2(21,596,299-21,740,274)×1</td><td colspan="1" rowspan="1">METTL9<xref ref-type="table-fn" rid="T2TFN1">*</xref>, IGSF6<xref ref-type="table-fn" rid="T2TFN1">*</xref>, OTOA<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>7769</bold></td><td colspan="1" rowspan="1">575.16</td><td colspan="1" rowspan="1">arr[hg19] 16q23.1(78,434,692-79,009,852)×3</td><td colspan="1" rowspan="1">WWOX<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>7769</bold></td><td colspan="1" rowspan="1">281.388</td><td colspan="1" rowspan="1">arr[hg19] 16q23.1q23.2(79,191,466-79,472,854)×3</td><td colspan="1" rowspan="1">WWOX<xref ref-type="table-fn" rid="T2TFN1">*</xref></td></tr><tr><td colspan="1" rowspan="1"><bold>9266</bold></td><td colspan="1" rowspan="1">252.225</td><td colspan="1" rowspan="1">arr[hg19] 18q22.2(68,060,722-68,312,947)×3</td><td colspan="1" rowspan="1">GTSCR1</td></tr></tbody></table><table-wrap-foot><fn id="T2TFN1"><p>*OMIM genes</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>The character of genes with two cases overlap</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Gene</th><th align="left" colspan="1" rowspan="1">Case ID</th><th align="left" colspan="1" rowspan="1">Loss/gain</th><th align="left" colspan="1" rowspan="1">Location [hg19]</th><th align="left" colspan="1" rowspan="1">Function</th><th align="left" colspan="1" rowspan="1">OMIM</th><th align="left" colspan="1" rowspan="1">HI score</th><th align="left" colspan="1" rowspan="1">DDG2P</th><th align="left" colspan="1" rowspan="1">Phenotype of decipher cases</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><bold>LPP</bold></td><td colspan="1" rowspan="1">9266,1471</td><td colspan="1" rowspan="1">Loss</td><td colspan="1" rowspan="1">3:187871072-188608460</td><td colspan="1" rowspan="1">LIM domain containing preferred translocation partner in lipoma</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">4.34</td><td colspan="1" rowspan="1">_</td><td colspan="1" rowspan="1">+</td></tr><tr><td colspan="1" rowspan="1"><bold>MEF2C</bold></td><td colspan="1" rowspan="1">3101, 7857</td><td colspan="1" rowspan="1">Loss</td><td colspan="1" rowspan="1">5:88013975-88199922</td><td colspan="1" rowspan="1">Myocyte enhancer factor 2C</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">0.26</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">+</td></tr><tr><td colspan="1" rowspan="1"><bold>CHRNA7</bold></td><td colspan="1" rowspan="1">1248, 0842</td><td colspan="1" rowspan="1">Gain</td><td colspan="1" rowspan="1">15:32322691-32464722</td><td colspan="1" rowspan="1">Cholinergic receptor, nicotinic, α 7 (neuronal)</td><td colspan="1" rowspan="1">+</td><td colspan="1" rowspan="1">40.52</td><td colspan="1" rowspan="1">_</td><td colspan="1" rowspan="1">+</td></tr></tbody></table><table-wrap-foot><fn><p>DDG2P, the Developmental Disorders Genotype-Phenotype Database; HI, haploinsufficiency.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="T4" orientation="portrait" position="float"><label>Table 4.</label><caption><title>Genes of functional classification by using WebGestalt</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Function</th><th align="left" colspan="1" rowspan="1">Gene ratio (total gene 487)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1"><bold>Moleclular function categories</bold></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"><bold>  Protein binding</bold></td><td colspan="1" rowspan="1">166/487</td></tr><tr><td colspan="1" rowspan="1"><bold>   Lon binding</bold></td><td colspan="1" rowspan="1">116/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Nucleic acid binding</bold></td><td colspan="1" rowspan="1">61/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Nucleic binding</bold></td><td colspan="1" rowspan="1">54/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Hydrolase activity</bold></td><td colspan="1" rowspan="1">47/487</td></tr><tr><td colspan="1" rowspan="1"><bold>Biological process categories</bold></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"><bold>  Metabolic process</bold></td><td colspan="1" rowspan="1">196/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Biological regulation</bold></td><td colspan="1" rowspan="1">168/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Response to stimulus</bold></td><td colspan="1" rowspan="1">141/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Multicellular organismal process</bold></td><td colspan="1" rowspan="1">122/487</td></tr><tr><td colspan="1" rowspan="1"><bold>Developmental process</bold></td><td colspan="1" rowspan="1">98/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Cellular component categories</bold></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"><bold>  Membrane</bold></td><td colspan="1" rowspan="1">155/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Nucleus</bold></td><td colspan="1" rowspan="1">106/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Macromolecular comples</bold></td><td colspan="1" rowspan="1">75/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Membrane-enclosed lumen</bold></td><td colspan="1" rowspan="1">66/487</td></tr><tr><td colspan="1" rowspan="1"><bold>  Cytosol</bold></td><td colspan="1" rowspan="1">44/487</td></tr></tbody></table></table-wrap></p>
<p>Comparing the CNV regions with the CNVs in the above databases (dbVar database, FARI gene database, NDAR database), we found 472 (84.1% of total) CNV regions overlapping with those in the databases (<xref ref-type="fig" rid="F1">Figure 1</xref>). There are 89 CNV regions that do not overlap with the databases. In addition, we compared the CNVs in our ASD samples with CNVs in the normal individuals and identified the CNVs in our ASD samples showing significantly different from those of normal individuals. Then we compared them with those in the databases. At this time, there were 72 CNVs (87.8% of the total) overlapping with the databases and there were 10 CNVs not overlapping with databases.</p>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<title>Number of overlapped CNV regions with Sfari, ClinVar and NDAD</title>
</caption>
<graphic xlink:href="bsr-37-bsr20160570-g1"></graphic>
</fig>
<p>As those genes show significantly different CNVs amongst ASD patients and normal controls, they are related with the ASD. In the interaction network of those genes, the known ASD genes are mostly at the core position and the significant genes found in our samples are closely related to the known genes. Amongst the significant genes, <italic>MAPK11, TSC2</italic>, and <italic>F10</italic> are also at the core position (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<title>Interaction network of our CNVs genes</title>
</caption>
<graphic xlink:href="bsr-37-bsr20160570-g2"></graphic>
</fig>
</sec>
<sec id="sec4" sec-type="discussion">
<title>Discussion</title>
<p>In the present study, we used a conceptually different approach, evaluating CNV hotspots across 64 ASD samples to analyze the human genome using vast, readily available databases with previously reported clinically relevant CNVs from human populations, thereby enhancing the current understanding of the etiology of CNVs in ASDs. Several microdeletion/microduplication syndromes detected through CMA have shown symptoms including ASD and comparison of the data with other ASD database found that 472 (84.1% of total) CNV regions overlap with these databases. Thus, the results of the present study are consistent with previous studies showing that CNVs are one of the multiple factors contributing to the development of an ASD phenotype [<xref ref-type="bibr" rid="B7">7</xref>].</p>
<p>In the present study, one autism-related CNV deletion gene was identified : <italic>MEF2C</italic> (<xref ref-type="table" rid="T3">Table 3</xref>). In particular, <italic>MEF2C</italic> exhibited a high HI score (e.g., 0–10%), indicating that these genes have a higher likelihood of exhibiting HI, with the most obvious pathogenic mechanism being heterozygous loss-of-function mutations (such as large, rare deletions) where a functional copy of a gene is insufficient to maintain the normal function [<xref ref-type="bibr" rid="B12">12</xref>]. As it was known that the transcription factors of the myocyte enhancer factor 2 family (MEF2 A–D) are highly expressed in the brain and play a key role in neuronal survival/apoptosis, differentiation and synaptic plasticity [<xref ref-type="bibr" rid="B13">13</xref>]. Previous study also showed that <italic>MEF2C</italic> limits excessive synapse formation during activity-dependent refinement of synaptic connectivity and thus facilitates hippocampal-dependent learning and memory [<xref ref-type="bibr" rid="B14">14</xref>]. In fact, increasing evidence has demonstrated the relevance of synapse dysfunction as a major determinant in many neurological diseases including autism [<xref ref-type="bibr" rid="B15">15</xref>]. Thus, the results of the present study provided evidence that the MEF2C deletion might be a factor for the induction of autism.</p>
<p>Recent studies have identified more than 103 genes and 44 genomic loci with mutations among individuals with some form of ASD [<xref ref-type="bibr" rid="B16">16</xref>]. The CNV-contained genes found in our study, <italic>MAPK11, TSC2</italic>, and <italic>F10</italic> are the known ASD-associated genes, which locate at the core position of interaction network, indicating that those CNVs were associated with ASD and they may contribute to ASD by affecting the ASD-related genes. In the present study, enrichment analysis showed that the 520 genes are most likely to be associated with membrane components with protein-binding functions involving metabolic processes, reflecting the tardive dyskinesia in autism and providing the biological basis of autism susceptibility. Based on the previous study, several metabolic defects have been associated with autistic symptoms with a rate higher than that found in the general population, and, inborn errors of metabolism (IEM) can probably account for less than 5% of individuals [<xref ref-type="bibr" rid="B17">17</xref>]. In addition, inherited metabolic disorders (IMD) responsible for ASDs are usually identified via clinical manifestations such as microcephaly, dysmorphic features, convulsions, and hepatosplenomegaly, and, patients with no additional clinical symptoms suggestive of an IMD may be diagnosed as having an idiopathic ASD [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Indeed, genetic factors leading to the abnormal expression of nerve growth associated proteins, enzymes, receptors, and neurotransmitters result in the abnormal proliferation and differentiation of neurones, including excessive trim, abnormal synaptic connections, and abnormal neural circuits [<xref ref-type="bibr" rid="B20">20–23</xref>]. As a result, it is logical that genes with associated metabolic disorders may also be considered as candidate ASDs’ genes.</p>
<p>In addition, genome variations are one of the genetic etiology of human disease. In the field of autism, point mutation is the top priority in the researches related with pathological genetic characteristics [<xref ref-type="bibr" rid="B24">24–26</xref>]. Several human syndromes derived from a single gene mutation increase the risk for ASD: such as fragile X-chromosome syndrome and Timothy syndrome [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Except for CNVs, CMA platform cannot detect other genome variations, such as point mutation, which could at least explain the patients without CNVs in our study.</p>
</sec>
<sec id="sec5" sec-type="conclusions">
<title>Conclusion</title>
<p>The investigation of the CNVs associated with ASD is promising for deciphering the genetic effects of these diseases. With the strategy of our study by genotyping 64 ASD patients, the results suggest that CNVs are one of the multiple factors contributing to the development of an ASD. The pathogenesis at least includes: (i) genes with metabolic disorders associated may be considered as candidate ASDs genes; (ii) CNV contains genes are functionally and closely related to the known ASDs genes. These results also reveal a significant gap in the function of non-coding genes for autism, which should be analyzed in follow-up studies. As microarrays remain the gold standard for CNV detection, further studies on CNVs to identify new genes that might contribute to ASDs will continue.</p>
<sec id="sec5-1">
<title>Summary of findings</title>
<p>
<list list-type="bullet">
<list-item>
<p>Copy number variations (CNVs) are one of the multiple factors contributing to the development of an autism spectrum disorder (ASD) phenotype.</p>
</list-item>
<list-item>
<p>The myocyte enhancer factor 2 family (MEF2C) deletion might be a factor in the induction of autism.</p>
</list-item>
<list-item>
<p>Genes associated with metabolic disorders may also be considered as candidate ASD genes.</p>
</list-item>
<list-item>
<p>ASD genes found in our samples are closely related to the known ASD genes.</p>
</list-item>
</list>
</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>We thank the clinical cytogenetic laboratory for aiding in data collection. We also thank the patients and their families.</p>
</ack>
<sec id="sec6" sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that there are no competing interests associated with the manuscript.</p>
</sec>
<sec id="sec7" sec-type="funding">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation Committee of China [grant number NSFC-81500974 (to X.Y.)]; the Natural Science Foundation of Guangdong Province [grant number 2014A030312012]; the International Cooperation Project of Science and Technology Planning Project of Guangdong Province [grant numbers 2013B51000087, 2016A030308011]; the Science and Information Technology of Guangzhou Key Project [grant numbers 201508020258, 201400000003-4, 201400000004-4]; and the Youth Project by Education of Guangdong Province [grant number B16036095].</p>
</sec>
<sec id="sec8" sec-type="author-contrib">
<title>Author contribution</title>
<p>X.Y. and S.X. conceived and designed the experiments. Y.H., Z.L., and S.B. performed the experiments. X.Y., Z.J., W.M., and Q.Y. analyzed the data. X.Y. and Y.H. wrote the paper. All authors read and approved the manuscript.</p>
</sec>
<glossary>
<title>Abbreviations</title>
<def-list list-content="abbreviations">
<def-item>
<term id="G1">ASD</term>
<def>
<p>autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term id="G2">CNV</term>
<def>
<p>copy number variation</p>
</def>
</def-item>
<def-item>
<term id="G3">CMA</term>
<def>
<p>chromosomal microarray analysis</p>
</def>
</def-item>
<def-item>
<term id="G4">GO</term>
<def>
<p>Gene Ontology</p>
</def>
</def-item>
<def-item>
<term id="G5">HI</term>
<def>
<p>haploinsufficiency</p>
</def>
</def-item>
<def-item>
<term id="G6">IEM</term>
<def>
<p>inborn errors of metabolism</p>
</def>
</def-item>
<def-item>
<term id="G7">IMD</term>
<def>
<p>inherited metabolic disorder</p>
</def>
</def-item>
<def-item>
<term id="G8">MEF2</term>
<def>
<p>myocyte enhancer factor 2 family</p>
</def>
</def-item>
<def-item>
<term id="G9">NDAD</term>
<def>
<p>National Database for Autism Research</p>
</def>
</def-item>
<def-item>
<term id="G10">qPCR</term>
<def>
<p>quantitative polymerase chain reaction</p>
</def>
</def-item>
<def-item>
<term id="G11">S.D.</term>
<def>
<p>standard deviation</p>
</def>
</def-item>
<def-item>
<term id="G12">SNP</term>
<def>
<p>single nucleotide polymorphism</p>
</def>
</def-item>
</def-list>
</glossary>
<ref-list>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname><given-names>B.</given-names></name> and <name><surname>Scherer</surname><given-names>S.W.</given-names></name></person-group> (<year>2012</year>) <article-title>Genetic architecture in autism spectrum disorder</article-title>. <source/>Curr. Opin. Genet. Dev.
<volume>22</volume>, <fpage>229</fpage>–<lpage>237</lpage><pub-id pub-id-type="pmid">22463983</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fombonne</surname><given-names>E.</given-names></name></person-group> (<year>2005</year>) <article-title>Epidemiology of autistic disorder and other pervasive developmental disorders</article-title>. <source/>J. Clin. Psychiatry
<volume>66</volume>, <fpage>3</fpage>–<lpage>8</lpage></mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X.</given-names></name>, <name><surname>Leotta</surname><given-names>A.</given-names></name>, <name><surname>Kustanovich</surname><given-names>V.</given-names></name>, <name><surname>Lajonchere</surname><given-names>C.</given-names></name>, <name><surname>Geschwind</surname><given-names>D.H.</given-names></name>, <name><surname>Law</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2007</year>) <article-title>A unified genetic theory for sporadic and inherited autism</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>104</volume>, <fpage>12831</fpage>–<lpage>12836</lpage><pub-id pub-id-type="pmid">17652511</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hehir-Kwa</surname><given-names>J.Y.</given-names></name>, <name><surname>Pfundt</surname><given-names>R.</given-names></name>, <name><surname>Veltman</surname><given-names>J.A.</given-names></name> and <name><surname>de Leeuw</surname><given-names>N.</given-names></name></person-group> (<year>2013</year>) <article-title>Pathogenic or not? Assessing the clinical relevance of copy number variants</article-title>
<source/>Clin. Genet.
<volume>84</volume>, <fpage>415</fpage>–<lpage>421</lpage><pub-id pub-id-type="pmid">23895381</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angkustsiri</surname><given-names>K.</given-names></name>, <name><surname>Goodlin-Jones</surname><given-names>B.</given-names></name>, <name><surname>Deprey</surname><given-names>L.</given-names></name>, <name><surname>Brahmbhatt</surname><given-names>K.</given-names></name>, <name><surname>Harris</surname><given-names>S.</given-names></name> and <name><surname>Simon</surname><given-names>T.J.</given-names></name></person-group> (<year>2014</year>) <article-title>Social impairments in chromosome 22q11.2 deletion syndrome (22q11.2DS): autism spectrum disorder or a different endophenotype?</article-title>
<source/>J. Autism Dev. Disord.
<volume>44</volume>, <fpage>739</fpage>–<lpage>746</lpage><pub-id pub-id-type="pmid">24045981</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazzellone</surname><given-names>M.J.</given-names></name>, <name><surname>Zhou</surname><given-names>X.</given-names></name>, <name><surname>Lionel</surname><given-names>A.C.</given-names></name>, <name><surname>Uddin</surname><given-names>M.</given-names></name>, <name><surname>Thiruvahindrapuram</surname><given-names>B.</given-names></name>, <name><surname>Liang</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2014</year>) <article-title>Copy number variation in Han Chinese individuals with autism spectrum disorder</article-title>. <source/>J. Neurodev. Disord.
<volume>6</volume>, <fpage>34</fpage><pub-id pub-id-type="pmid">25170348</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shishido</surname><given-names>E.</given-names></name>, <name><surname>Aleksic</surname><given-names>B.</given-names></name> and <name><surname>Ozaki</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>) <article-title>Copy-number variation in the pathogenesis of autism spectrum disorder</article-title>. <source/>Psychiatry Clin. Neurosci.
<volume>68</volume>, <fpage>85</fpage>–<lpage>95</lpage><pub-id pub-id-type="pmid">24372918</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabet</surname><given-names>A.C.</given-names></name>, <name><surname>Verloes</surname><given-names>A.</given-names></name>, <name><surname>Pilorge</surname><given-names>M.</given-names></name>, <name><surname>Delaby</surname><given-names>E.</given-names></name>, <name><surname>Delorme</surname><given-names>R.</given-names></name>, <name><surname>Nygren</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2015</year>) <article-title>Complex nature of apparently balanced chromosomal rearrangements in patients with autism spectrum disorder</article-title>. <source/>Mol. Autism
<volume>6</volume>, <fpage>19</fpage><pub-id pub-id-type="pmid">25844147</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X.</given-names></name>, <name><surname>Xu</surname><given-names>Y.</given-names></name>, <name><surname>Wang</surname><given-names>J.</given-names></name>, <name><surname>Zhou</surname><given-names>H.</given-names></name>, <name><surname>Liu</surname><given-names>X.</given-names></name>, <name><surname>Ayub</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2011</year>) <article-title>Replication of the association of a MET variant with autism in a Chinese Han population</article-title>. <source/>PLoS ONE
<volume>6</volume>, <fpage>e27428</fpage><pub-id pub-id-type="pmid">22110649</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yingjun</surname><given-names>X.</given-names></name>, <name><surname>Wen</surname><given-names>T.</given-names></name>, <name><surname>Yujian</surname><given-names>L.</given-names></name>, <name><surname>Lingling</surname><given-names>X.</given-names></name>, <name><surname>Huimin</surname><given-names>H.</given-names></name>, <name><surname>Qun</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2015</year>) <article-title>Microduplication of chromosome Xq25 encompassing STAG2 gene in a boy with intellectual disability</article-title>. <source/>Eur. J. Med. Genet.
<volume>58</volume>, <fpage>116</fpage>–<lpage>121</lpage><pub-id pub-id-type="pmid">25450604</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimand</surname><given-names>J.</given-names></name>, <name><surname>Arak</surname><given-names>T.</given-names></name> and <name><surname>Vilo</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>) <article-title>g:Profiler–a web server for functional interpretation of gene lists (2011 update)</article-title>. <source/>Nucleic Acids Res.
<volume>39</volume>, <fpage>W307</fpage>–<lpage>W315</lpage><pub-id pub-id-type="pmid">21646343</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>N.</given-names></name>, <name><surname>Lee</surname><given-names>I.</given-names></name>, <name><surname>Marcotte</surname><given-names>E.M.</given-names></name> and <name><surname>Hurles</surname><given-names>M.E.</given-names></name></person-group> (<year>2010</year>) <article-title>Characterising and predicting haploinsufficiency in the human genome</article-title>. <source/>PLos Genet.
<volume>6</volume>, <fpage>e1001154</fpage><pub-id pub-id-type="pmid">20976243</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Q.</given-names></name> and <name><surname>Telese</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>) <article-title>Genome-wide epigenetic analysis of MEF2A and MEF2C transcription factors in mouse cortical neurons</article-title>. <source/>Commun. Integr. Biol.
<volume>8</volume>, <fpage>e1087624</fpage><pub-id pub-id-type="pmid">27066173</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>A.C.</given-names></name>, <name><surname>Kim</surname><given-names>M.S.</given-names></name>, <name><surname>Ertunc</surname><given-names>M.</given-names></name>, <name><surname>Adachi</surname><given-names>M.</given-names></name>, <name><surname>Nelson</surname><given-names>E.D.</given-names></name>, <name><surname>McAnally</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2008</year>) <article-title>MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>105</volume>, <fpage>9391</fpage>–<lpage>9396</lpage><pub-id pub-id-type="pmid">18599438</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lepeta</surname><given-names>K.</given-names></name>, <name><surname>Lourenco</surname><given-names>M.V.</given-names></name>, <name><surname>Schweitzer</surname><given-names>B.C.</given-names></name>, <name><surname>Martino Adami</surname><given-names>P.V.</given-names></name>, <name><surname>Banerjee</surname><given-names>P.</given-names></name>, <name><surname>Catuara-Solarz</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2016</year>) <article-title>Synaptopathies: synaptic dysfunction in neurological disorders</article-title>. <source/>J. Neurochem.
<volume>138</volume>, <fpage>785</fpage>–<lpage>805</lpage><pub-id pub-id-type="pmid">27333343</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betancur</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>) <article-title>Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting</article-title>. <source/>Brain Res.
<volume>1380</volume>, <fpage>42</fpage>–<lpage>77</lpage><pub-id pub-id-type="pmid">21129364</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzi</surname><given-names>B.</given-names></name>, <name><surname>Loizzo</surname><given-names>A.L.</given-names></name>, <name><surname>Giana</surname><given-names>G.</given-names></name> and <name><surname>Curatolo</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>) <article-title>Autism and metabolic diseases</article-title>. <source/>J. Child Neurol.
<volume>23</volume>, <fpage>307</fpage>–<lpage>314</lpage><pub-id pub-id-type="pmid">18079313</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campistol</surname><given-names>J.</given-names></name>, <name><surname>Diez-Juan</surname><given-names>M.</given-names></name>, <name><surname>Callejon</surname><given-names>L.</given-names></name>, <name><surname>Fernandez-De Miguel</surname><given-names>A.</given-names></name>, <name><surname>Casado</surname><given-names>M.</given-names></name>, <name><surname>Garcia Cazorla</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>) <article-title>Inborn error metabolic screening in individuals with nonsyndromic autism spectrum disorders</article-title>. <source/>Dev. Med. Child. Neurol.
<volume>58</volume>, <fpage>842</fpage>–<lpage>847</lpage><pub-id pub-id-type="pmid">27038397</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiykim</surname><given-names>E.</given-names></name>, <name><surname>Zeybek</surname><given-names>C.A.</given-names></name>, <name><surname>Zubarioglu</surname><given-names>T.</given-names></name>, <name><surname>Cansever</surname><given-names>S.</given-names></name>, <name><surname>Yalcinkaya</surname><given-names>C.</given-names></name>, <name><surname>Soyucen</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2016</year>) <article-title>Inherited metabolic disorders in Turkish patients with autism spectrum disorders</article-title>. <source/>Autism Res.
<volume>9</volume>, <fpage>217</fpage>–<lpage>223</lpage><pub-id pub-id-type="pmid">26055667</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anitha</surname><given-names>A.</given-names></name>, <name><surname>Nakamura</surname><given-names>K.</given-names></name>, <name><surname>Thanseem</surname><given-names>I.</given-names></name>, <name><surname>Matsuzaki</surname><given-names>H.</given-names></name>, <name><surname>Miyachi</surname><given-names>T.</given-names></name>, <name><surname>Tsujii</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2013</year>) <article-title>Downregulation of the expression of mitochondrial electron transport complex genes in autism brains</article-title>. <source/>Brain Pathol.
<volume>23</volume>, <fpage>294</fpage>–<lpage>302</lpage><pub-id pub-id-type="pmid">23088660</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>M.L.</given-names></name>, <name><surname>Pramparo</surname><given-names>T.</given-names></name>, <name><surname>Winn</surname><given-names>M.E.</given-names></name>, <name><surname>Barnes</surname><given-names>C.C.</given-names></name>, <name><surname>Li</surname><given-names>H.R.</given-names></name>, <name><surname>Weiss</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2012</year>) <article-title>Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages</article-title>. <source/>PLoS Genet.
<volume>8</volume>, <fpage>e1002592</fpage><pub-id pub-id-type="pmid">22457638</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S.H.</given-names></name> and <name><surname>Folsom</surname><given-names>T.D.</given-names></name></person-group> (<year>2014</year>) <article-title>GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism</article-title>. <source/>Schizophr. Res.
<volume>167</volume>, <fpage>42</fpage>–<lpage>56</lpage><pub-id pub-id-type="pmid">25432637</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakatani</surname><given-names>J.</given-names></name>, <name><surname>Tamada</surname><given-names>K.</given-names></name>, <name><surname>Hatanaka</surname><given-names>F.</given-names></name>, <name><surname>Ise</surname><given-names>S.</given-names></name>, <name><surname>Ohta</surname><given-names>H.</given-names></name>, <name><surname>Inoue</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2009</year>) <article-title>Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism</article-title>. <source/>Cell
<volume>137</volume>, <fpage>1235</fpage>–<lpage>1246</lpage><pub-id pub-id-type="pmid">19563756</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AlSagob</surname><given-names>M.</given-names></name>, <name><surname>Colak</surname><given-names>D.</given-names></name> and <name><surname>Kaya</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>) <article-title>Genetics of autism spectrum disorder: an update on copy number variations leading to autism in the next generation sequencing era</article-title>. <source/>Discov. Med.
<volume>19</volume>, <fpage>367</fpage>–<lpage>379</lpage><pub-id pub-id-type="pmid">26105700</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metsu</surname><given-names>S.</given-names></name>, <name><surname>Rainger</surname><given-names>J.K.</given-names></name>, <name><surname>Debacker</surname><given-names>K.</given-names></name>, <name><surname>Bernhard</surname><given-names>B.</given-names></name>, <name><surname>Rooms</surname><given-names>L.</given-names></name>, <name><surname>Grafodatskaya</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2014</year>) <article-title>A CGG-repeat expansion mutation in ZNF713 causes FRA7A: association with autistic spectrum disorder in two families</article-title>. <source/>Hum. Mutat.
<volume>35</volume>, <fpage>1295</fpage>–<lpage>1300</lpage><pub-id pub-id-type="pmid">25196122</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>C.L.</given-names></name>, <name><surname>Chen</surname><given-names>H.I.</given-names></name>, <name><surname>Li</surname><given-names>L.H.</given-names></name>, <name><surname>Chien</surname><given-names>Y.L.</given-names></name>, <name><surname>Liao</surname><given-names>H.M.</given-names></name>, <name><surname>Chou</surname><given-names>M.C.</given-names></name><etal></etal></person-group> (<year>2016</year>) <article-title>Genome-wide analysis of copy number variations identifies PARK2 as a candidate gene for autism spectrum disorder</article-title>. <source/>Mol. Autism
<volume>7</volume>, <fpage>23</fpage><pub-id pub-id-type="pmid">27042285</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.S.</given-names></name>, <name><surname>Li</surname><given-names>C.</given-names></name>, <name><surname>Wang</surname><given-names>C.H.</given-names></name>, <name><surname>Amuta</surname><given-names>A.</given-names></name>, <name><surname>Li</surname><given-names>M.</given-names></name>, <name><surname>Huang</surname><given-names>T.Y.</given-names></name><etal></etal></person-group> (<year>2015</year>) <article-title>Autism spectrum disorders: perceptions of genetic etiology and recurrence risk among Taiwanese parents of affected children</article-title>. <source/>Clin. Genet.
<volume>88</volume>, <fpage>129</fpage>–<lpage>134</lpage><pub-id pub-id-type="pmid">25267333</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>J.J.</given-names></name>, <name><surname>Berrios</surname><given-names>J.</given-names></name>, <name><surname>Newbern</surname><given-names>J.M.</given-names></name>, <name><surname>Snider</surname><given-names>W.D.</given-names></name>, <name><surname>Philpot</surname><given-names>B.D.</given-names></name>, <name><surname>Hahn</surname><given-names>K.M.</given-names></name><etal></etal></person-group> (<year>2015</year>) <article-title>An autism-linked mutation disables phosphorylation control of UBE3A</article-title>. <source/>Cell
<volume>162</volume>, <fpage>795</fpage>–<lpage>807</lpage><pub-id pub-id-type="pmid">26255772</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>